SOURCE: MAQUET

MAQUET

January 31, 2011 08:00 ET

MAQUET Cardiovascular Launches New ACROBAT-i Stabilizer and Positioner System for Off-Pump Coronary Artery Bypass Graft Surgery

WAYNE, NJ--(Marketwire - January 31, 2011) - MAQUET Cardiovascular today launched its new ACROBAT-i Stabilizer and Positioner System at the Society of Thoracic Surgery Meeting in San Diego. Developed for use in performing off-pump coronary artery bypass (OPCAB) procedures on coronary artery bypass graft (CABG) patients, this next-generation ACROBAT-i System, the latest in the ACROBAT family, has a significantly lower profile design and tubing management features that allow increased access to and visibility of the surgical field. With 180˚ side to side range of motion and the stabilizer's ability to vertically drop into the chest cavity, its maneuverability and arm strength help cardiovascular surgeons gain better access and control for hard-to-reach vessels during CABG surgery.

"With the new design of the arm for the ACROBAT-i Stabilizer, visualization during Off-Pump Cardiovascular Bypass surgery is much improved," said Dr. Reza Khalafi from Plaza Medical Center of Fort Worth, Texas. "This is especially noticeable for creating anastomoses on the lateral wall and back side of the heart, making the OPCAB procedure easier to perform."

In a CABG procedure, a healthy blood vessel, such as the saphenous vein, from the leg, or the radial artery, from the arm, is used to bypass a blockage in the heart. The vessel anastomoses is done during OPCAB, also called "beating heart" surgery, which is performed without the use of cardiopulmonary bypass (also known as a "heart-lung machine"). Studies have shown that OPCAB reduces patient mortality, improves post-surgery neurological outcomes and shortens recovery times compared with on-pump surgery.

"The new ACROBAT-i System enabled me to see and do more during CABG performed on a beating heart," said Dr. Marc Katz from St. Mary's Hospital in Richmond, VA. "The ACROBAT-i System will help me reach and stabilize hard to visualize vessels on OPCAB cases." 

The ACROBAT-i Stabilizer and Positioner System combines industry-leading strength and stability with elegant and unprecedented functionality. "With the ACROBAT-i System, MAQUET remains at the forefront of developing and designing cardiovascular products that will minimize surgical risk and benefit patients. This latest advancement in beating heart technology takes OPCAB to a new level," said Patrick Walsh, President of the MAQUET Cardiovascular Cardiac Surgery business unit. 

About MAQUET Cardiovascular
MAQUET Cardiovascular is a leader in providing innovative products for cardiac surgery, vascular intervention and cardiac support to hospitals and clinics and the cardiac surgeons, interventional cardiologists, perfusionists and other healthcare professionals who care for patients with cardiovascular disease. MAQUET Cardiovascular is focused on providing clinicians with future-oriented technology that fits into their daily practice and improves the therapeutic management of patients. MAQUET Cardiovascular continues to invest in the development of innovative technologies and solutions that advance clinical practice, improve patient outcomes and enhance quality of life.

MAQUET Cardiovascular was formed in 2003 when MAQUET, the world's leading medical technology company, combined its existing Cardiopulmonary business (equipment and consumables for open heart surgery) and the ventilator business in Critical Care, which the publicly-listed Swedish GETINGE Group acquired in 2003. In 2008, MAQUET added the Cardiac Surgery and Vascular Interventions businesses acquired by GETINGE from Boston Scientific and Guidant. In 2009, it added the Cardiac Assist businesses that GETINGE acquired from Datascope. MAQUET Cardiovascular provides healthcare professionals with products in four business units: Cardiopulmonary (perfusion products), Cardiac Surgery (clampless beating heart and endoscopic vessel harvesting), Vascular Interventions (grafts for vascular surgery), and Cardiac Assist (intra-aortic balloon counterpulsation therapy).

About The MAQUET Group
The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR), Cath Lab, Intensive Care Unit (ICU) and Patient Transport. The integrated products of MAQUET are specially designed to deliver optimal clinical treatment and therapeutic applications within acute care hospitals. MAQUET provides innovative medical solutions from three Divisions:

  • Cardiovascular with products for cardiac assist (intra-aortic balloon counterpulsation therapy), coronary artery bypass surgery, complex aortic surgery reconstruction, peripheral interventions and extracorporeal circulation
  • Critical Care for intensive care ventilators and anesthesia machines
  • Surgical Workplaces for OR tables, lights and ceiling service units, flexible room design for OR, Cath Lab and ICU as well as digital OR integration

MAQUET is a subsidiary of the publicly-listed Swedish GETINGE GROUP, a company with around $3 billion in revenue (2009 fiscal year) and 12,100 employees worldwide. In 2009 MAQUET itself generated revenue of around $1.5 billion. The company now has more than 5,000 employees in 36 international sales and service organizations, as well as a network of more than 250 distributors. Twelve manufacturing sites are located in six countries.

www.maquet.com
www.getingegroup.com

MAQUET - The Gold Standard.